Cleveland Clinic, Taussig Cancer Institute (111) — Cleveland, Ohio

Cleveland Clinic, Taussig Cancer Institute (111) is a clinical research site located in Cleveland, Ohio, United States 44195.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Cleveland Clinic, Taussig Cancer Institute (111) has participated in 1 clinical trials.

Therapeutic areas: AML With Monocytic Differentiation, CMML.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cleveland Clinic, Taussig Cancer Institute (111)?

Cleveland Clinic, Taussig Cancer Institute (111) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cleveland Clinic, Taussig Cancer Institute (111) conducted?

Cleveland Clinic, Taussig Cancer Institute (111) has 1 clinical trials on record. Their work covers AML With Monocytic Differentiation, CMML.

Is Cleveland Clinic, Taussig Cancer Institute (111) accredited by Crixeo Health?

Cleveland Clinic, Taussig Cancer Institute (111) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cleveland Clinic, Taussig Cancer Institute (111)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.